中康控股2024年度报告

Contents 2Corporate Information5Core Financial and Operational Data7Financial Summary8Chairman’s Statement15Management Discussion and Analysis55Directors and Senior Management61Directors’ Report100Corporate Governance Report117Environmental, Social and Governance Report180Independent Auditor’s Report191Consolidated Statement of Profit or Lossand Other Comprehensive Income192Consolidated Statement of Financial Position194Consolidated Statement of Changes in Equity196Consolidated Statement of Cash Flows200Notes to Financial Statements341Definitions 2CORPORATE INFORMATION BOARD OF DIRECTORSExecutive DirectorsMr. Wu Yushu(Chairman)Ms. Wang Lifang Non-executive DirectorMr. Fu Haitao Independent Non-executive Directors Ms. Wang DanzhouMs. Du YilinMr. Wei Bin AUDIT COMMITTEE Mr. Wei Bin(Chairman)Ms. Wang DanzhouMs. Du Yilin REMUNERATION COMMITTEE Ms. Wang Danzhou(Chairperson)Ms. Du YilinMs. Wang Lifang NOMINATION COMMITTEE Mr. Wu Yushu(Chairman)Ms. Du YilinMs. Wang Danzhou AUTHORISED REPRESENTATIVES Mr. Wu YushuMs. Zhang Xiao COMPANY SECRETARYMs. Zhang XiaoACG, HKACG ACGHKACG Sinohealth Holdings Limited2024 ANNUAL REPORT REGISTERED OFFICE IN THE CAYMAN ISLANDS 89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands 89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands PRINCIPAL PLACE OF BUSINESS IN THE PRC 51111 Room 1111, No.5 Wangjiang Second StreetHuangge Town, Nansha DistrictGuangzhou CityGuangdong ProvincePRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG 1357732 Room 732, 7th Floor, Rykadan Tower135 Hoi Bun Road, Kwun TongKowloonHong Kong CAYMAN ISLANDS PRINCIPAL SHAREREGISTRAR AND TRANSFER OFFICE Ogier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands Ogier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands HONG KONG SHARE REGISTRAR ANDTRANSFER OFFICE 148212103B Boardroom Share Registrars (HK) Limited2103B, 21/F148 Electric RoadNorth PointHong Kong 4CORPORATE INFORMATION LEGAL ADVISERS 15323203-3207 As to Hong Kong lawJingtian & Gongcheng LLPSuites 3203-320732/F, Edinburgh TowerThe Landmark15 Queen’s Road CentralHong Kong 101045 As to PRC lawJingtian & Gongcheng45/F, K.Wah Centre1010 Huaihai Road (M)ShanghaiChina AUDITOR 979127 Ernst& YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong PRINCIPAL BANKS 76 Ping An Bank Guangzhou Huangpu Avenue Branch1/F, Fulilong SquareNo. 76 Huangpu Avenue WestTianhe DistrictGuangzhou CityGuangdong ProvincePRC STOCK CODE 2361 2361 ir.sinohealth.cn Sinohealth Holdings Limited2024 ANNUAL REPORT 5CORE FINANCIAL AND OPERATIONAL DATA 6CORE FINANCIAL AND OPERATIONAL DATA EFFICIENT DATA PROCESSING CAPACITY高效的數據處理能力 ACCURATE DATA VALUE MINING ABILITY精準的數據價值挖掘能力 全方位的生態賦能體系All-round Ecological Empowerment System The Group has established a portfolio of healthcare industry conferences/exhibition events andmedia services to build a valuable ecological chain for industry participants. It is also the mainscene of the Group's product marketing and "traffic monetisation". 本集團搭建的健康產業會議/會展活動和媒介服務組合，為行業參與者構建價值生態鏈，同時也是本集團產品行銷及“流量變現”的主要場景。 CPEO held successfully for 17 sessions, has become a forward-looking industry conference withleading position in China's healthcare industry in terms of specifications, scale and influence. Therewere 8,000 official participants and more than 60,000 participants, reaching a new high in scale.西普會已成功舉辦十七屆，發展成為中國健康產業規格領先、規模領先、影響力領先的前瞻性產業會議，正式參會嘉賓8,000人，參會人數超6萬人，規模再創新高。 Industrial Ecological Platform had reached to a total of nearly one million industry professionals.產業生態平台觸達行業事業人士合計近百萬。 202220232024123120222023202020211231 The following is a summary of the Group’s published resultsand assets and liabilities for the past five financial years. Thefinancial information for the year ended 31 December 2022,2023 and 2024 is extracted from the consolidated financialstatements of 2022, 2023 and this annual report, and thefinancial information for the years ended 31 December 2020,2021 is extracted from the Prospectus. CHAIRMAN’S STATEMENT8 2024AI(2023)2023GDP7.2%AIAI In 2024, despite the complex and variable global economysituation, the healthcare industry showed strong resilienceand vitality due to support from national policies and thepromotion of the AI technology revolution. According to the“Chinese Medical Terminal Market Blue Book (2023)” ((2023)) published by the SinohealthIndustry Research Institute, although the growth rate wasslightly slowed down, the pharmaceutical industry abovedesignated size showed an overall upward trend. The totalhealth expenditure of China in 2023 only accounted for 7.2%of the total GDP, representing a large room for improvementas compared to developed countries. The above factors,coupled with the intensification of population ageing, changesin the disease spectrum, and the growing health demandsof the public, indicate that the healthcare i